Profusa (PFSA) Gains from Investment Securities (2022 - 2026)
Profusa (PFSA) posted quarterly Gains from Investment Securities of -$258000.0 for Q1 2026, down 262.95% year-over-year from $158335.0 in Q1 2025, and down 124.09% quarter-over-quarter from $1.1 million in Q4 2025.
Profusa (PFSA) Gains from Investment Securities (2022 - 2026) Analysis & Trends
Profusa's Gains from Investment Securities history runs 5 years deep, the most recent figure standing at -$258000.0 for Q1 2026.
- In Q1 2026, Gains from Investment Securities fell 262.95% year-over-year to -$258000.0; the TTM figure through Mar 2026 stood at $5.8 million (up 2130.08% YoY), while the FY2025 annual figure was $187000.0, down 65.34% from the prior year.
- Gains from Investment Securities for Q1 2026 stood at -$258000.0, down from $1.1 million in the prior quarter.
- The five-year high for Gains from Investment Securities was $5.9 million in Q2 2025, with the low at -$3.9 million in Q1 2022.
- The 5-year median for Gains from Investment Securities is -$41991.0 (2022), against an average of $44813.0.
- The sharpest annual moves came in 2023 and 2025: Gains from Investment Securities slumped 932.37% in 2023, then soared 1900.0% in 2025.
- Profusa's Gains from Investment Securities stood at -$111338.0 in 2022, then plunged by 359.02% to -$511069.0 in 2023, then surged by 122.02% to $112531.0 in 2024, then soared by 851.74% to $1.1 million in 2025, then sank by 124.09% to -$258000.0 in 2026.
- Business Quant data shows PFSA's Gains from Investment Securities at -$258000.0 in Q1 2026, $1.1 million in Q4 2025, and -$884000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn |
| 2 | Stryker | 127.42 Bn | 123.95 Bn | 4.50 Bn |
| 3 | Medtronic | 118.97 Bn | 109.75 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.97 Bn | 47.72 Bn | 1.35 Bn |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn |
| 10 | Profusa | 124,279.61 | -250,720.39 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -258,000.00 |
| Mar 31, 2026 | -258,000.00 |
| Dec 31, 2025 | 1.07 Mn |
| Dec 31, 2025 | 1.07 Mn |
| Sep 30, 2025 | -884,000.00 |
| Sep 30, 2025 | -884,000.00 |
| Jun 30, 2025 | 5.92 Mn |
| Jun 30, 2025 | 5.92 Mn |
| Mar 31, 2025 | 158,335.00 |
| Mar 31, 2025 | 158,335.00 |
| Dec 31, 2024 | 112,531.00 |
| Dec 31, 2024 | 112,531.00 |
| Sep 30, 2024 | -304,575.00 |
| Sep 30, 2024 | -304,575.00 |
| Jun 30, 2024 | 295,872.00 |
| Jun 30, 2024 | 295,872.00 |
| Mar 31, 2024 | 213,077.00 |
| Mar 31, 2024 | 213,077.00 |
| Dec 31, 2023 | -511,069.00 |
| Dec 31, 2023 | -511,069.00 |